SEIR Model — Susceptible-Exposed-Infectious-Recovered Compartmental Model
Also known as: Susceptible-Exposed-Infectious-Recovered Model, SEIR Compartmental Model, Latent Period Epidemic Model, SEIR Bulaşıcı Hastalık Modeli
The SEIR model is a deterministic compartmental model that partitions a closed population into four epidemiological states: Susceptible (S), Exposed (E), Infectious (I), and Recovered (R). It extends the classic SIR framework by explicitly incorporating a latent period during which individuals have been infected but are not yet infectious. The model was systematically formalized by Anderson and May (1991) and remains a cornerstone of mathematical epidemiology for diseases with non-negligible incubation periods.
Key highlights
- Explicitly models the incubation period, producing more realistic epidemic curves than the SIR model for many pathogens.
- Mathematically tractable: closed-form threshold conditions and R0 expressions are available.
- Easily extended to include vaccination, age structure, spatial heterogeneity, or multiple strains.
- Widely validated against empirical outbreak data for influenza, COVID-19, measles, and other diseases.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use the SEIR model when the pathogen of interest has a biologically meaningful incubation period — influenza, COVID-19, measles, Ebola — and when a deterministic approximation is acceptable for a large, well-mixed population. Key assumptions include homogeneous mixing, constant population size, and exponentially distributed stage durations. For small populations, stochastic variants are preferred. When immunity wanes, an SEIRS extension is appropriate. When multiple transmission routes or age structure matter, structured or network models should be considered instead.
Strengths & limitations
- Explicitly models the incubation period, producing more realistic epidemic curves than the SIR model for many pathogens.
- Mathematically tractable: closed-form threshold conditions and R0 expressions are available.
- Easily extended to include vaccination, age structure, spatial heterogeneity, or multiple strains.
- Widely validated against empirical outbreak data for influenza, COVID-19, measles, and other diseases.
- Assumes homogeneous mixing, which ignores network structure, spatial clustering, and social heterogeneity.
- Exponential sojourn time in each compartment is often biologically unrealistic; Erlang-staged extensions add complexity.
- Deterministic formulation breaks down for small populations or when stochastic extinction is epidemiologically relevant.
- Parameter estimation (beta, sigma, gamma) requires reliable surveillance data, which may be unavailable in resource-limited settings.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
What is the difference between the SIR and SEIR models?
The SIR model assumes that infection is immediately infectious upon contact, while the SEIR model inserts an Exposed compartment representing the incubation period during which individuals are infected but not yet able to transmit. This delay shifts the epidemic peak later in time and can substantially reduce peak height, making SEIR more appropriate for diseases like influenza or COVID-19.
How is R0 calculated in the SEIR framework?
In the standard SEIR model with frequency-dependent transmission, R0 equals beta divided by gamma, identical to the SIR formula. The exposed compartment does not alter R0 because E individuals do not transmit; they only affect the timing of the epidemic. R0 represents the average number of secondary infections produced by one infectious individual in a fully susceptible population.
Can the SEIR model account for reinfection or waning immunity?
The standard SEIR model assumes permanent immunity after recovery. Waning immunity is handled by the SEIRS extension, which adds a flow from R back to S at a rate reflecting the duration of protection. For pathogens with partial or strain-specific immunity, multi-strain SEIR models or more complex immunological structures are required.
Sources
- 1.Anderson, R. M., & May, R. M. (1991). Infectious Diseases of Humans: Dynamics and Control. Oxford University Press.ISBN 978-0-19-854040-3
You have read it. What now?
Cite this page
ScholarGate. (2026, June 2). SEIR Model. ScholarGate. https://scholargate.app/epidemiology/seir-model